The aim of this study is to investigate the changes in expression and activ
ity of inducible nitric oxide synthase (iNOS) in the developing murine embr
yo and mouse and human placenta. Using reverse transcription-polymerase cha
in reaction (RT-PCR), Northern blotting, and in-situ hybridization (ISH) we
identified iNOS mRNA in mouse placenta at 9.5, 12, 14, 16, 18 and 20 days
post coitum. Northern blot analysis demonstrated that the quantity of murin
e iNOS transcript was expressed at a stable level between days 12-20 althou
gh the level of calcium-independent NOS activity declined with advancing ge
station. RT-PCR detected iNOS-specific mRNA in murine embryonic stem cells,
but not in embryos at later stages (4-cell or blastocyst), ISH failed to s
how iNOS-specific mRNA in either murine placenta or the underlying myometri
um on day 7, but did so in the trophoblast by day 9.5. Later in gestation,
extensive labelling was observed in both spongiotrophoblast and trophoblast
giant cells. iNOS mRNA was also detected both in immature human placentae
(16-18 weeks) and at term, predominantly in syncytiotrophoblasts and placen
tal artery smooth muscle. In conclusion, iNOS is constitutively expressed i
n mouse and human placenta at a time and in a location that suggests a role
in placentation.